MenuMENU
Meetings & Events > Conferences & Courses > Annual Scientific Meeting > 2013 Annual Scientific Meeting > 2013 ASM Syllabus Home Page > Day 1 Agenda and Syllabus

RecycleACMT125wThe Changing Faces of Antidotes

Web-based Syllabus

Instructions:

Lecture slides are available as PDFs in color (1 slide per page) and black & white (3 slides per page). Only material submitted by the lecturer is available.The files contained on these pages are the intellectual property of the American College of Medical Toxicology and, the authors and speakers. No unauthorized download, copy or distribution of these files is permitted.

Click on Color or B&W for the lecture you would like, or right-click and select "Save As..."

Please note that the web-based syllabus will be updated as new or revised material is made available. When re-visiting the syllabus, please refresh your browser to ensure access to recent updates. Breakout sessions may feature handouts that will be made available during individual sessions.

A printed syllabus will not be available for attendees in San Juan. Please print material you require prior to arrival.

 

Day 1

Friday, March 15, 2013

Syllabus

Content

7:00-7:55am
Committee Meetings

7:00-7:55am   Addiction Medicine Section, Atlantic Room I

7:00-7:55am   International Committee, Atlantic Room ll

7:00-7:55am   Fellowship Directors, Miramar Room

Committee & Section Meetings Complete Schedule
7:55-8:00am
Welcome and Introductions
President, American College of Medical Toxicology
 
Chair, 2013 Annual Scientific Meeting Planning Committee
 
8:00-9:00am
Platform Session 1
Moderators: Theodore C. Bania, MD and Todd Mitchell, MD, MPH

Pilot Trial of Lipid Rescue in a Swine Model of Severe Nifedipine Toxicity
Christine Murphy, MD

Pretreatment with Intravenous Lipid Emulsion Reduces Mortality from Cocaine Toxicity in a Rat Model
Stephanie Carreiro, MD

A Swine Model of Severe Propranolol Toxicity Permitting Direct Measurement of Cerebral Oxygen Tension
Benjamin S Orozco, MD

Signs, Symptoms, and Functional Impairment During Recovery from Copperhead Snakebite
Eric Lavonas, MD, FACMT

All Abstracts - JMT PDF
9:00-9:45am
Toxicological Evaluation and Treatment of Patients with Metal Prostheses
Jeffrey Brent, MD, PhD, FACMT
9:45-10:00am Break  
10:00-11:30am Breakout Workshops: Attend 2/3 sessions  
A.  Fomepizole: Patient Tailored vs. Standardized Therapy
Anthony F. Pizon, MD, FACMT
B.  NAC: Dosing Strategies Beyond the Package Insert
Paul I. Dargan, MB, BS, FRCPE, FACMT
C.  The Newest "Antidote": Novel Use for Methylene Blue
Christine Murphy, MD
11:30-11:45am Break & Lunch Pick-Up  
11:45-12:30pm
Presidential Keynote Address: Building a Research Pipeline at NIH
David A. Jett, PhD
Program Director, NIH Countermeasures Agains Chemical Threats
12:30-1:00pm Amanita Toxicity: Silybinin and Biliary Drainage
Todd Mitchell, MD, MPH
1:00-1:15pm Break  
1:15-2:00pm Professional Development: Concurrent Workshops  
A.  Media Relations: We Can Be Better Than Dr. Oz!
Anne-Michelle Ruha, MD, FACMT
B.  Telemedicine Toxicology Service
G. Patrick Daubert, MD, FACMT and Steven R. Offerman, MD, FACMT
C. 
Building a Career in Antidote Research: Can You Mesh a Clinical and Academic Practice?
Kennon Heard, MD, FACMT
2:00-4:30pm Afternoon Break and Committee Meetings  
 

2:00-3:30pm   ToxIC Meeting, Atlantic Room I & ll

2:00-4:30pm   JMT Editorial Board Meeting, Miramar Room

3:30-4:30pm   Practice Committee, Grand Ballroom ll

3:30-4:30pm   Public Affairs Committee, Ocean Park Room

3:30-4:30pm   Resident / Student Greet & Meet, Foyer Lower Level

 Committee & Section Meetings Complete Schedule
4:30-6:30pm Fellows-in-Training Concurrent Sessions
 
OpenMicLogo
Fellows-in-Training Open Mic Session   
  Fellows-in-Training Research Forum  
6:30-8:30pm
President's Reception and Induction of New College Fellows
Condado Terrace, San Juan Marriott Resort & Stellaris Casino
 
 

Go to Day 2, March 16

Go to Day 3, March 17

 
 
 

Faculty

BrentJ

Dr. Jeffrey Brent is a Distinguished Clinical Professor of Medicine and Pediatrics at the University of Colorado, School of Medicine, and Clinical Professor of Environmental and Occupational Medicine at the School of Public Health.   He is the recipient of numerous honors and awards. Dr. Brent is the senior editor of Critical Care Toxicology: The Diagnosis and Treatment of the Acutely Poisoned Patient, is former Editor of Toxicological Reviews, and a member of the Editorial Board of Clinical Toxicology. He is a former President of the AACT and a former Board member of the ACMT. Dr. Brent’s areas of research are multi-center collaborations - specifically the development and application of the ToxIC network and Registry,   methods used to diagnose mercury toxicity in autistic children by alternative medicine practitioners, the limitations of hair testing and provoked urine specimens in the evaluation of toxic exposures and injury, and the epidemiology of poisonings in infants, pregnancy and the elderly. In addition to his M.D., Dr. Brent holds a Ph.D. in biochemistry.

Carreriro125w

Dr. Stephanie Carreiro is currently completing her fourth year of Emergency Medicine Residency at Brown University in Providence, Rhode Island, and will pursue a fellowship in Medical Toxicology at the University of Massachusetts upon graduation.  Her research interests include antidotal properties and potential drug interactions of intravenous lipid emulsion therapy, opiate abuse and novel drugs of abuse.

Dargan125

Dr. Paul I. Dargan is a Consultant Physician and Clinical Toxicologist and Clinical Director at Guy's and St Thomas' NHS Foundation Trust, London, UK. He is also a Reader in Toxicology at King's College London. He has an active research and teaching programme with a focus on recreational drug toxicity, self-poisoning and heavy metal toxicity. He has published over 130 peer-reviewed papers and numerous book chapters. He sits on the Advisory Council on the Misuse of Drugs (ACMD) and is an expert adviser to a number of other bodies including the European Monitoring Centre for Drugs and Drugs Addiction EMCDDA), the US Food and Drug Administration (FDA) and the World Health Organisation (WHO).

Daubert125w

Dr. G. Patrick Daubert is an Army veteran with the 1st Infantry Division and received his undergraduate education in biomedical engineering at The University of Iowa (Go Hawks!). He graduated from St. George’s University School of Medicine following his military service. He completed his internship and residency in Emergency Medicine at Wayne State University/Detroit Medical Center. This was followed by a toxicology fellowship with at the Children’s Hospital of Michigan in Detroit. Dr. Daubert currently works for Kaiser Permanente as part of their Northern California Regional Toxicology Service. He is the past Director of Clinical and Medical Toxicology Education at the University of California, Davis, Medical Center and past Program Director for the Fellowship in Medical Toxicology. He was previously an Associate Medical Director, Sacramento Division, of the California Poison Control System. His areas of interest include pediatric lead poisoning, poisonous plants and fellow-in-training education. In addition, Dr. Daubert is an avid road and mountain cyclist and races/rides off-road motorcycles.

Heard Photo

Dr. Kennon Heard is Medical Toxicology Fellowship Director at the Rocky Mountain Poison and Drug Center and Associate Professor of Emergency Medicine at the University Of Colorado School Of Medicine. He works and teaches at the University Of Colorado Hospital Emergency Department.  He has been teaching emergency medicine principle and toxicology on all levels since 1999. His research interests include antidotes, cocaine toxicity, misuse of over-the-counter analgesics, acetaminophen poisoning, geriatric pharmacology and research design.  He has participated in 12 clinical trials, and has been primary investigator for three.  He has authored over 100 papers and 20 book chapters in various areas of Emergency Medicine and Medical Toxicology.

Jett_Photo

Dr. David A. Jett is a Program Director at the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Jett is the Program Director for the NIH Countermeasures Against Chemical Threats (CounterACT) Program designed to develop new drugs and diagnostic tools for treating victims of chemical exposures during an emergency. After receiving a Ph.D. in Neuropharmacology and Toxicology at the University of Maryland, School of Medicine, Dr. Jett conducted post-doctoral research and subsequently joined the faculty at Johns Hopkins University's Bloomberg School of Public Health where he conducted research as a university professor for several years. Dr. Jett's scientific interest is in the impact of chemical agents on nervous system function, including the molecular and cellular mechanisms of cognitive and neural development. Specifically he has expertise and experience with organophosphorus pesticides and nerve agents, and the heavy metal lead. Dr. Jett’s other major interest at NINDS are programs designed to increase diversity in the neuroscience research workforce.

Kerns125w Dr. William Russ Kerns, lll is a faculty member of the Department of Emergency Medicine at the Carolinas Medical Center in Charlotte, NC. After graduating from Randolph-Macon College, Dr. Kerns received his medical degree from Medical College of Virginia, and then completed a residency in Emergency Medicine and a medical toxicology fellowship at the Carolinas Medical Center, Charlotte, NC.  His academic mission focuses exclusively on toxicology and includes bedside and poison center patient care, resident and fellow education, coordination of toxicology research, and contribution to local and state educational programs. Since 2000, he has directed the Carolinas Medical Toxicology Fellowship training program. Dr. Kerns also endeavors to promote toxicology at the national level through participation in education and research programs. Participation in ACMT efforts have included the Journal of Medical Toxicology editorial board, Instructor for the Board Review and Agents of Opportunity courses , ToxIC contributor, Program Director Committee, and Research Committee. As a current member of the ACMT Board of Directors his goal is to continue the advancement of medical toxicology in the areas of education and research.
Lavonas125w

Dr. Eric Lavonas, a native of upstate New York, is the associate director of the Rocky Mountain Poison and Drug Center. After graduating from University of Rochester, he received his medical degree from State University of New York Health Science Center at Syracuse. He completed his residency in Emergency Medicine at Methodist Hospital of Indiana, and completed a fellowship in Medical Toxicology at Carolinas Medical Center. He particularly enjoys collaborative projects; recently, he has been involved with the ILCOR and American Heart Association ALS working groups, the ACEP Clinical Policies Committee, the Undersea & Hyperbaric Medicine sub-board, and the CDC CO poisoning surveillance working group. He has been an ACMT member since 1999. Dr. Lavonas has also chaired the ACMT By-laws committee for 6 years, and currently chairs the Liaison committee. 

Mitchell Dr. Todd Mitchell is boarded in Family Medicine and Geriatrics and works as a hospitalist in Santa Cruz, CA. His involvement with amatoxin poisoning began in 2007 when he obtained an Emergency FDA IND and arranged for the treatment of six amatoxin poisoned patients with intravenous silibinin air couriered from Germany. Dr Mitchell later proposed the initiation of a nationwide prospective open clinical trial, approved by the FDA in 2009. In 2011, Dr Mitchell participated in the care of amatoxin cohort in Assam, India; the first patients to be treated with percutaneous biliary drainage. Dr Mitchell’s overall goal is the establishment of a universal standard of care for patients with amatoxin poisoning.
Murphy125w

Dr. Christine Murphy received her BS and MA degrees in Chemistry from the College of William and Mary in Williamsburg, Virginia.  She completed both medical school and her Emergency Medicine residency at Virginia Commonwealth University in Richmond, Virginia.  She rounded out her post-graduate work with completion of a Medical Toxicology fellowship in Charlotte, North Carolina.  Currently an Assistant Professor in the Department of Emergency of Medicine and Division of Clinical Toxicology at Virginia Commonwealth University, she routinely teaches residents from all specialties, pharmacy students, and pharmacy residents.  She specifically enjoys the field of Pediatric Toxicology.  Research interests currently include new antidotes and recreational drugs of abuse, specifically “bath salts” products.

Offerman125w

Dr. Steven R. Offerman is a board-certified Medical Toxicologist based at the Kaiser Permanente South Sacramento facility.  He is the Director of the regional Toxicology consultation service.  Dr. Offerman trained at UC Davis in emergency medicine and completed fellowship in Medical Toxicology at UC San Diego.  He came to Kaiser South Sacramento in December 2006 from UC Davis where he was on faculty.  He is assistant medical director for the California Poison Control System, Sacramento Division and conducts clinical research in the area of Medical Toxicology.

Orozco Dr. Benjamin S. Orozco is a second year toxicology fellow at HealthPartners Institute for Medical Education and Research and Hennepin Regional Poison Center in St.Paul/Minneapolis, Minnesota and currently serves at President of the Medical Toxicology Fellows in Training Association.  Dr. Orozco received his medical degree from Harvard Medical School in 2008, and subsequently completed an emergency medicine residency at Hennepin County Medical Center in 2011. 
Pizon125w

Dr. Anthony F. Pizon is an Assistant Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Medical Director of the West Virginia Poison Center and Fellowship Director of the Medical Toxicology Fellowship at the University of Pittsburgh Medical Center. Dr. Pizon received his medical degree at the Medical College of Ohio in 2001.  He completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and completed his medical toxicology fellowship training at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is board-certified in both Emergency Medicine and Medical Toxicology.

Ruha125w

Dr. Anne-Michelle Ruha received her medical degree from UMDNJ New Jersey Medical School and then completed an Emergency Medicine residency at Morristown Memorial Hospital in New Jersey. Her fellowship training brought her to Phoenix, Arizona, where she continues to serve as Director of the Medical Toxicology Fellowship at Banner Good Samaritan Medical Center.  She is Board Certified in Emergency Medicine and Medical Toxicology but her clinical practice is focused on providing care to poisoned and envenomed patients. She is a Clinical Assistant Professor with the Department of Emergency Medicine at the University of Arizona College of Medicine and also serves on the Medical Toxicology Subboard for the American Board of Emergency Medicine, the certifying organization for medical toxicologists.  Dr. Ruha is an Editorial Board member and the Review Article Editor for the Journal of Medical Toxicology. Her major area of interest and research is in envenomations. Dr. Ruha has been a member of the Board of Directors of the American College of Medical Toxicology since 2009.

WhiteS125w

Dr. Suzanne R. White completed her undergraduate education at Adrian College. She received her medical degree and completed her residency in emergency medicine and medical toxicology at Wayne State University. In addition to receiving an MBA from the University of Tennessee, Dr. White also completed the Executive Leadership in Academic Medicine Fellowship at Drexel University. Dr. White is board certified in Emergency Medicine and Medical Toxicology, and is a practicing medical toxicologist and emergency physician. Dr. White is the past Medical Director for the Children’s Hospital of Michigan Regional Poison Control Center. She is the Emergency Physician-in-Chief for the Detroit Medical Center and the Dayandan Professor and Chair of Emergency Medicine at Wayne State University School of Medicine. In January 2011, Dr. White was named Executive Vice President and Chief Medical Officer of the Detroit Medical Center. Dr. White has chaired the Medical Toxicology Subboard of the American Board of Emergency Medicine. Dr. White has served as the Chair of the ACMT Awards Committee and Education Committee. She currently serves on the ACGME RRC for EM and the American Board of Pharmaceutical Specialties. Dr. White has interests in the areas of poison prevention, disaster, bioterrorism and weapons of mass destruction preparedness.